Clinical Trials Browser

Phase 2 × Panitumumab × Head & Neck × Clear all

Squamous Cell Carcinoma of Head and Neck

NCT00446446 2022-10-05

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Phase 2 Completed

52 enrolled 17 charts

Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02643056 2021-10-27

S10PANI01

Phase 2 Completed

32 enrolled

Head & Neck

Advanced Head and Neck Squamous Cancer

NCT01264328 2019-04-16

VECTITAX

Phase 2 Completed

40 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00756444 2018-11-15

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

67 enrolled 8 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT00500760 2018-10-17

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Phase 2 Completed

153 enrolled 18 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00798655 2017-10-03

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

Phase 2 Completed

46 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT00547157 2017-03-15

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

152 enrolled 18 charts

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT01634880 2016-05-23

Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

Phase 2 Withdrawn

Head & Neck

Salivary Gland Malignancy

NCT01312493 2015-08-28

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

Phase 2 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT01305772 2014-08-29

TOP0901

Phase 2 Terminated

6 enrolled 6 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

S10PANI01

VECTITAX

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

TOP0901